Cytarabine in Treating Young Patients With Recurrent or Refractory Ewing's Sarcoma
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Holcombe E. Grier, MD
Dana-Farber Cancer Institute
Principal Investigator - Kimberly Stegmaier, MD
Dana-Farber Cancer Institute
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
73 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- University of Alberta Hospital
Edmonton, Alberta, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Children'S Hospital of Eastern Ontario
Ottawa, Ontario, Canada
- Hospital for Sick Children
Toronto, Ontario, Canada
- Hopital Sainte Justine
Montreal, Quebec, Canada
- Montreal Children'S Hospital at Mcgill University Health Center
Montreal, Quebec, Canada
- Centre Hospitalier Universitaire de Quebec
Québec, Canada
- San Jorge Children'S Hospital
Santurce, Puerto Rico
- Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Birmingham, Alabama, United States
- Arizona Cancer Center at University of Arizona Health Sciences Center
Tucson, Arizona, United States
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Southern California Permanente Medical Group
Downey, California, United States
- Children'S Hospital Central California
Madera, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Ucsf Helen Diller Family Comprehensive Cancer Center
San Francisco, California, United States
- Carole and Ray Neag Comprehensive Cancer Center at the University of Connecticut Health Center
Farmington, Connecticut, United States
- Lombardi Comprehensive Cancer Center at Georgetown University Medical Center
Washington D.C., District of Columbia, United States
- Lee Cancer Care of Lee Memorial Health System
Fort Myers, Florida, United States
- All Children'S Hospital
St. Petersburg, Florida, United States
- St. Joseph'S Cancer Institute at St. Joseph'S Hospital
Tampa, Florida, United States
- Kaplan Cancer Center at St. Mary'S Medical Center
West Palm Beach, Florida, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Children'S Memorial Hospital - Chicago
Chicago, Illinois, United States
- Simmons Cooper Cancer Institute
Springfield, Illinois, United States
- Indiana University Melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Lucille P. Markey Cancer Center at University of Kentucky
Lexington, Kentucky, United States
- Tulane Cancer Center Office of Clinical Research
Alexandria, Louisiana, United States
- Alvin and Lois Lapidus Cancer Institute at Sinai Hospital
Baltimore, Maryland, United States
- Dana-Farber/harvard Cancer Center at Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Massachusetts General Hospital
Boston, Massachusetts, United States
- C.S. Mott Children'S Hospital at University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Butterworth Hospital at Spectrum Health
Grand Rapids, Michigan, United States
- University of Mississippi Cancer Clinic
Jackson, Mississippi, United States
- Children'S Mercy Hospital
Kansas City, Missouri, United States
- Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - Saint Louis
St Louis, Missouri, United States
- Sunrise Hospital and Medical Center
Las Vegas, Nevada, United States
- Hackensack University Medical Center Cancer Center
Hackensack, New Jersey, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2007
- Primary completion
- 31 Aug 2008
- Completion
- 31 Dec 2013
- Last update posted
- 20 Oct 2014
- Registered enrollment
- 10
- Registry id
- NCT00470275
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.